# CARMUSTINE
> **ANDA214117** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-12-27
## Drug
- **FDA Application Number:** ANDA214117
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARMUSTINE
- **Generic name:** Carmustine
- **Active ingredients:** CARMUSTINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2022-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214117)
---
*MORVS · CC0 1.0*